Chloe Friedman

Chloe Friedman

Auto-generated profile, based on publicly available information

Chloe Friedman

Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA; Lifecourse Epidemiology of Adiposity and Diabetes (LEAD) Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2021 in Environmental Research
Verified
Journal Article
Closed access
CFChloe Friedman
Chloe Friedman
DDDana Dabelea
Dana Dabelea
DTDeborah Thomas
Deborah Thomas
JPJennifer L. Peel
Jennifer L. Peel
JAJohn L. Adgate
John L. Adgate
ASAnne P. Starling
Anne P. Starling

3 March 2022 in Epigenetics
Verified
Journal Article
Open access
LKLeanne K. Küpers
Leanne K. Küpers
SFSílvia Fernández-Barrés
Sílvia Fernández-Barrés
ANAayah Nounu
Aayah Nounu
CFChloe Friedman
Chloe Friedman
RFRuby Fore
Ruby Fore
JFJanine F. Felix
Janine F. Felix
Higher adherence to the Mediterranean diet during pregnancy is related to a lower risk of preterm birth and to better offspring cardiometabolic health. DNA methylation may be an underlying biological mechanism. We evaluated whether maternal adherence to the Mediterranean diet was associated with offspring cord blood DNA methylation. We meta-analysed epigenome-wide association studies (EWAS) of maternal adherence to the Mediterranean diet during pregnancy and offspring cord blood DNA methylation in 2802 mother–child pairs from five cohorts. We calculated the relative Mediterranean diet (rMED) score with range 0–18 and an adjusted rMED excluding alcohol (rMEDp, range 0–16). DNA methylation was measured using Illumina 450K arrays. We used robust linear regression modelling adjusted for child sex, maternal education, age, smoking, body mass index, energy intake, batch, and cell types. We performed several functional analyses and examined the persistence of differential DNA methylation into childhood (4.5–7.8 y). rMEDp was associated with cord blood DNA methylation at cg23757341 (0.064% increase in DNA methylation per 1-point increase in the rMEDp score, SE = 0.011, P = 2.41 × 10−8). This cytosine–phosphate–guanine (CpG) site maps to WNT5B, associated with adipogenesis and glycaemic phenotypes. We did not identify associations with childhood gene expression, nor did we find enriched biological pathways. The association did not persist into childhood. In this meta-analysis, maternal adherence to the Mediterranean diet (excluding alcohol) during pregnancy was associated with cord blood DNA methylation level at cg23757341. Potential mediation of DNA methylation in associations with offspring health requires further study.

10 October 2019 in Journal of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
CFChloe Friedman
Chloe Friedman
MLMadison Lyon
Madison Lyon
RTRobert Torphy
Robert Torphy
DTDaniel Thieu
Daniel Thieu
PHPatrick Hosokawa
Patrick Hosokawa
AGAna Gleisner
Ana Gleisner

11 July 2022 in Environmental Research
Verified
Journal Article
Closed access
ASAnne P. Starling
Anne P. Starling
CWCheyret Wood
Cheyret Wood
CLCuining Liu
Cuining Liu
KKKaterina Kechris
Katerina Kechris
IYIvana V. Yang
Ivana V. Yang
DDDana Dabelea
Dana Dabelea

2 December 2023 in International Journal of Obesity
Verified
Journal Article
Closed access
PDF file
ASAnne P. Starling
Anne P. Starling
CFChloe Friedman
Chloe Friedman
KBKristen Boyle
Kristen Boyle
JAJohn L. Adgate
John L. Adgate
DGDeborah H. Glueck
Deborah H. Glueck
DDDana Dabelea
Dana Dabelea

16 June 2023 in Environmental Epidemiology
Verified
Journal Article
Open access
CFChloe Friedman
Chloe Friedman
DDDana Dabelea
Dana Dabelea
AKAlexander P. Keil
Alexander P. Keil
JAJohn L. Adgate
John L. Adgate
DGDeborah H. Glueck
Deborah H. Glueck
ASAnne P. Starling
Anne P. Starling
Background/objectives: Per- and polyfluoroalkyl substances (PFAS) are endocrine-disrupting chemicals that may affect breastfeeding duration. We examined associations between maternal PFAS concentrations during pregnancy and breastfeeding cessation. We investigated potential effect modification by parity status. Methods: Among 555 women enrolled in the Healthy Start study (2009–2014), we quantified maternal serum concentrations of 5 PFAS during mid- to late-pregnancy (mean 27 weeks of gestation). Participants self-reported their breastfeeding practices through 18–24 months postnatally. Among all participants and stratified by parity, we estimated associations between maternal PFAS concentrations and breastfeeding discontinuation by 3 and 6 months, using Poisson regression, and breastfeeding duration, using Cox regression. Results: Median PFAS concentrations were similar to those in the general US population. Associations between PFAS and breastfeeding duration differed by parity status. After adjusting for covariates, among primiparous women, associations between PFAS and breastfeeding cessation by 3 and 6 months were generally null, with some inverse associations. Among multiparous women, there were positive associations between perfluorohexane sulfonate, perfluorooctane sulfonate, perfluorooctanoate (PFOA), and perfluorononanoate and breastfeeding cessation by 3 and 6 months. For example, per ln-ng/mL increase in PFOA, the risk ratio for breastfeeding discontinuation by 6 months was 1.45 (95% confidence interval, 1.18, 1.78). Hazard ratios reflected similar patterns between PFAS and breastfeeding duration. Conclusions: Among primiparous women, we did not find evidence for associations between PFAS concentrations and breastfeeding duration. In contrast, among multiparous women, PFAS serum concentrations were generally inversely associated with breastfeeding duration, though estimates may be biased due to confounding by unmeasured previous breastfeeding.